ScholarGate
Assistent

Compara mètodes

Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.

Assaig Clínic Aleatoritzat per Fase III amb Assignació Emparellada×Estudi de cohort aparellat×
CampEpidemiologiaEpidemiologia
FamíliaProcess / pipelineProcess / pipeline
Any d'origenMid-20th century (matching in RCTs formalized ~1950s–1970s)Mid-20th century; propensity-score variant 1983
Autor originalFisher, R. A. (matching principles); adapted into confirmatory trial design over mid-20th centuryEstablished practice; propensity-score matching formalized by Rosenbaum & Rubin (1983)
TipusControlled confirmatory clinical trial with matchingObservational analytic study design
Font seminalRothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641
Àliesmatched controlled Phase III trial, Phase III matched-pair trial, matched confirmatory trial, matched late-phase RCTmatched follow-up study, paired cohort study, propensity-matched cohort, matched prospective study
Relacionats55
ResumA matched Phase III clinical trial is a confirmatory, late-stage controlled study in which each participant assigned to the experimental treatment is paired with one or more controls who share key prognostic characteristics — such as age, disease stage, or comorbidities — before treatment allocation. By ensuring baseline comparability at the level of matched pairs, the design reduces confounding and improves statistical efficiency in settings where simple randomization alone may produce imbalanced groups or where full randomization is logistically or ethically constrained.A matched cohort study is an observational design in which each exposed participant is paired with one or more unexposed counterparts who share key characteristics — such as age, sex, or comorbidity status — before both groups are followed forward in time to compare incident outcomes. Matching controls for measured confounders at the design stage, reducing bias that would otherwise require statistical adjustment alone.
ScholarGateConjunt de dades
  1. v1
  2. 2 Fonts
  3. PUBLISHED
  1. v1
  2. 2 Fonts
  3. PUBLISHED

Ves a la cerca Baixa les diapositives

ScholarGateCompara mètodes: Matched Phase III Clinical Trial · Matched Cohort Study. Recuperat el 2026-06-19 de https://scholargate.app/ca/compare